Abstract: A method and device for adaptively adjusting sound effect, and the method comprises: obtaining an energy value of the current ambient noise; receiving a first trigger instruction and adjusting the current output volume based on the energy value of the current ambient noise; while judging that the energy value of the current ambient noise is bigger than a first threshold, processing treble enhancement; while judging that the energy value of the current ambient noise is less than a second a sound threshold, processing bass enhancement. By collecting the voice data and detecting the speech activity on the voice data, when the first trigger instruction is received, the method can adjust the current volume and adjust the frequency response by the treble enhancement or the bass enhancement based on the energy value of the current ambient noise, thereby obtaining the better sound effect and easy to achieve.

Abstract: The present invention provides compounds, pharmaceutical compositions and methods for the treatment of specific cancers. Such compositions may generally comprise a compound of formula (I): wherein R1-R3 are as defined herein, or pharmaceutically acceptable salts or esters thereof; and a pharmaceutically acceptable carrier.

Abstract: The present invention provides compounds, pharmaceutical compositions and methods for the treatment of specific cancers. Such compositions may generally comprise a compound of formula (I): wherein R1-R3 are as defined herein, or pharmaceutically acceptable salts or esters thereof; and a pharmaceutically acceptable carrier.

Abstract: A method and device for adaptively adjusting sound effect, and the method comprises: obtaining an energy value of the current ambient noise; receiving a first trigger instruction and adjusting the current output volume based on the energy value of the current ambient noise; while judging that the energy value of the current ambient noise is bigger than a first threshold, processing treble enhancement; while judging that the energy value of the current ambient noise is less than a second a sound threshold, processing bass enhancement. By collecting the voice data and detecting the speech activity on the voice data, when the first trigger instruction is received, the method can adjust the current volume and adjust the frequency response by the treble enhancement or the bass enhancement based on the energy value of the current ambient noise, thereby obtaining the better sound effect and easy to achieve.

Abstract: A high priority service sending method and device in a direct mode, and a high priority service receiving method and device in a direct mode. The receiving method includes: after sending a voice frame in a voice call sending state, a user terminal receiving and detecting a priority frame in another time slot with respect to the time slot occupied by the voice call; and if the priority frame is detected, then stopping the voice call and receiving a high priority service frame in the other time slot. Using the present invention can enable an interphone in a transmitting state in a direct mode to send or receive a high priority service as well.

Abstract: The present invention provides compounds, pharmaceutical compositions and methods for the treatment of specific cancers. Such compositions may generally comprise a compound of formula (I): wherein R1-R3 are as defined herein, or pharmaceutically acceptable salts or esters thereof; and a pharmaceutically acceptable carrier.

Abstract: The present invention provides compositions and methods for effective treatment of a lysosomal acid lipase deficiency (LALD) disease, in particular, Wolman's disease and Cholesteryl Ester Storage Disease (CESD). Among other things, the present invention provides a method of treating a lysosomal acid lipase deficiency (LALD) disease, including administering to an individual suffering from or susceptible to the LALD disease a therapeutic effective amount of a lysosomal acid lipase periodically at an administration interval such that lipid level in liver, spleen and/or small intestine is reduced by at least 20% as compared to an untreated control.

Abstract: The present invention provides compounds, pharmaceutical compositions and methods for the treatment of specific cancers. Such compositions may generally comprise a compound of formula (I): wherein R1-R3 are as defined herein, or pharmaceutically acceptable salts or esters thereof; and a pharmaceutically acceptable carrier.

Abstract: A chemiluminescent composition comprising an oxalate and an activator component wherein at least one of said oxalate or activator components contains a fluorescer and at least one of said oxalate or activator components contains an organic polymer. The combined concentration of said organic polymer contained in both components is above 50% by weight of the total composition, and said organic polymer is an insoluble solid. Further, The activator component contains a peroxide at a concentration below 2% by weight of the total composition.

Abstract: The present invention provides compounds, methods for the synthesis thereof and methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis.

Abstract: A wireless access device communicates with a plurality of customer premised equipments (CPEs) via a network. The wireless access device establishes a plurality of queues and distributes intervals for each of the CPEs. The wireless access device receives packets from the network, obtains one of the intervals corresponding to one of the CPEs with a MAC address being a destination MAC address of one of the received packets, and stores each of the received packets to one of the queues with sequence number being in the obtained interval. The wireless access device transmits the received packets stored in the plurality of queues in the way of one row by one row.

Abstract: A method for calculating connectivity of a space having a number of objects using a computer system includes establishing a character matrix having a number of elements in accordance with the objects. A label matrix is established, and the character matrix is divided into blocks. Connectivity of the elements of each of the blocks is calculated, and then the elements are grouped into regions based on the values of the elements. Each of the regions is labeled and enhanced. Connectivity of the regions is calculated, and the regions are grouped into larger regions based on the values of the elements.

Abstract: An electronic system comprises a memory, a parser, and a device driver. A plurality of applications and a document are stored in a user space of the memory, the document storing configuration parameters. The parser module parses the document to retrieve the parameters in response to invocation from at least one application. The device driver creates data structure for the parameters in the kernel space of the memory, thus to facilitate a plurality of programs to execute different functions of the system by commonly utilizing the parameters through the device driver.

Abstract: Disclosed herein are methods and intermediates useful in the preparation of macrolides, e.g., compounds of formula (IV) wherein R1-R12 are as defined herein.

Abstract: A chemiluminescent composition comprising an oxalate and an activator component wherein at least one of said oxalate or activator components contains a fluorescer and at least one of said oxalate or activator components contains an organic polymer. The combined concentration of said organic polymer contained in both components is above 50% by weight of the total composition, and said organic polymer is an insoluble solid. Further, The activator component contains a peroxide at a concentration below 2% by weight of the total composition.

Abstract: In an electronic device and method of matching an image A and an image B, grayscale centers of the image A and the image B are computed. The image A is divided into n equal parts Dk(k=1˜n) according to the grayscale center, and a grayscale density Vk of each part Dk is computed, to acquire n grayscale densities Vk(k=1˜n) which are regarded as feature data u of the image A. Feature data v of the image B is extracted in the similar way. A similarity of a grayscale density Vak selected from the feature data u and the grayscale density Vbk selected from the feature data V, is computed. Thus, n similarities are computed. A similarity ?(n, u, v) of the image A and the image B is computed according to the n similarities.

Abstract: An electronic device creates a table for mapping a plurality of pressure values corresponding to a plurality of numerical values, and stores the pressure mapping table in a memory. The electronic device detects a touch on a touch panel of the electronic device and detects a value of the pressure of the touch. The electronic device obtains a numerical value corresponding to the detected pressure value in the pressure mapping table. The electronic device generates a password code as a result of user input based on the numerical value.

Abstract: The present invention provides methods for the use of compounds having formula (I) in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, t, X, Y, Z, and n are as defined herein.

Abstract: A method for calculating connectivity of a space having a number of objects using a computer system includes establishing a character matrix having a number of elements in accordance with the objects. A label matrix is established, and the character matrix is divided into blocks. Connectivity of the elements of each of the blocks is calculated, and then the elements are grouped into regions based on the values of the elements. Each of the regions is labeled and enhanced.

Abstract: A myeloid-specific c-fms-rtTA/(TetO)7-CMV-MMP12 bitransgenic mouse model was created. Induction of MMP12 abnormally elevated frequencies and numbers of common myeloid progenitor (CMP) and granulocyte/macrophage progenitor (GMP) populations, and decreased the frequency and number of the megakaryocyte/erythrocyte progenitor (MEP) population in bone marrow. CD11b+/Gr-1+ immature cell population increased in multiple organs. An immunosuppressive function on T cell proliferation and function by CD11b+/Gr-1+ immature cells was seen in vitro and in vivo from MMP12 over-expression. MMP12 stimulated (Lin?) progenitor cells to differentiate into CD11b+/Gr-1+ immature cells showing immunosuppression on T cell proliferation and function in vitro. Regulatory T cells were increased. In the lung, concentration of interleukin (IL)-6 was increased, which activated oncogenic signal transducer and increased expression of Stat3 downstream genes in epithelial tumor progenitor cells.